FridayMay 06, 2022 11:38 am

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Releases New Lightning Network Node in India, Leveraging Growth of Cryptocurrency Use in the Area

The global cryptocurrency market is expected to grow at a CAGR of 12.8%, to reach US $4.94 billion by 2030 The increase in cryptocurrency adoption worldwide has shown explosive market growth and the increased need for transaction facilitation like LQwD's PaaS protocol on the Lightning Network India ranks number two in the adoption and use of cryptocurrency Experts in the cryptocurrency industry estimate that India has more than 20 million crypto investors, with most growth being driven by users under the age of 35 LQwD currently has 10 active nodes on the Lightning Network with a capacity of over 10…

Continue Reading

FridayMay 06, 2022 11:12 am

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Schedules Webcast to Discuss 2021 Financial and Operating Results

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced that it will host a webcast at 9 a.m. ET on Tuesday, May 10, to discuss financial and operating results for its fiscal year ended Dec. 31, 2021. During the webcast, Flora’s management will deliver comments on financial results, operational highlights from 2021, as well as share a brief look at the company’s performance in 2022 thus far. Following the presentation, analysts, media and investors will be afforded the opportunity to ask questions in a Q&A session. Interested parties may join the webcast…

Continue Reading

FridayMay 06, 2022 9:00 am

The 2nd Annual Gene Therapy Summit To Share Insights On Safer Gene Therapy Programs

The 2nd Annual Gene Therapy Summit will take place June 7-9, 2022, in Boston, MA. With a focus on effectively engaging genetic therapy patients, this is a must attend summit for individuals and companies that are serious about building safer and more meaningful gene therapy programs. The summit will unite patient advocacy and engagement leaders from gene therapy and gene editing drug developers, patient groups and patients themselves to address the specific challenges of patient engagement in genetic therapy and will generate actionable insights through detailed case studies and open discussions.  As gene therapies proliferate and sector investment continues to…

Continue Reading

FridayMay 06, 2022 9:00 am

Cybin Inc.’s (NEO: CYBN) (NYSE American: CYBN) Proprietary CYB003 Set to Move Forward in First-in-Human Phase 1/2a Clinical Trial

Cybin has selected Clinilabs Drug Development Corporation as CRO for its Phase 1/2a clinical trial evaluating CYB003 for treating major depressive disorder (“MDD”) MDD impacts more than 264 million people worldwide, is a leading cause of mental disability worldwide Preclinical studies show CYB003 may have significant advantages over classic psilocybin In a significant step forward in the study of alternative treatments for major depressive disorder, Cybin (NEO: CYBN) (NYSE American: CYBN) is moving forward in its phase 1/2a clinical trial of its proprietary deuterated psilocybin, CYB003 (https://ibn.fm/VTjoI). Based on previous research, CYB003 has the potential to effectively treat MDD with significant…

Continue Reading

FridayMay 06, 2022 9:00 am

Kronos Advanced Technologies Inc. (KNOS) Venturing into Metaverse with Initial eCommerce Virtual Store

“Metaverse refers to digital worlds in which people will gather to work, play and hang out,” explains CNET article Kronos is one of the earliest companies to design and soon open its own metaverse virtual store Emergen Research reports that metaverse market reached $47.69 billion in 2020, by 2028 could see a revenue CAGR of 43.3% The metaverse is everywhere, popping up in entertainment and vying for news headlines. This immersive virtual world where people live, work, shop and interact through avatars once seemed like science fiction but is fast becoming a real-world fact. Savvy companies, including Kronos Advanced Technologies…

Continue Reading

ThursdayMay 05, 2022 3:00 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Demonstrating ‘Encouraging Promise in Treatment of GBM’

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical cancer drug developer, recently reported new advances in its rollout of a global clinical trial described as “potentially pivotal” in producing a treatment for an aggressive brain cancer, glioblastoma multiforme (“GBM”). On average, GBM is nearly 100% fatal just over a year into diagnosis. “CNS announced that France’s regulatory agencies have granted the company authority to pursue patient recruitment in the country…. France’s approval comes on the heels of similar authorization in Switzerland, where Swissmedic, the Swiss agency for therapeutic products, joined swissethics, the umbrella organization of the cantonal Ethics Committees (‘ECs’), in greenlighting…

Continue Reading

ThursdayMay 05, 2022 2:42 pm

QualityStocksNewsBreaks – Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Eyeing Expanded Physical Presence, Bolstered Functional Experience

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) CEO Marc Aneed, in a recent business letter, acknowledged how the ongoing COVID-19 pandemic, along with the Russia-Ukraine war, had taken a toll on supply chains but expressed utmost confidence in the company’s teams and partners. “Since its inception in 2020, Eat Well Investment Group has managed to deal with one challenge after another, always coming out on top. This has been evidenced by the company’s uninterrupted expansion moves that have seen the acquisition of Belle Pulses Ltd., Sapientia Technology Inc. and Amara Organic Foods. It is also demonstrated by its accelerated…

Continue Reading

ThursdayMay 05, 2022 2:06 pm

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Enters New Shopping Center Contract in Yonkers, New York

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, today announced that it has executed a new contract with a New York shopping center owner. The announcement reads, “Seven years ago yesterday, on Star Wars Day, Knightscope deployed its first robot at a popular Silicon Valley mall — an expanding use case with proven, ongoing successes. Protecting large parking lots and structures by enhancing existing security operations with a K5 Autonomous Security Robot (‘ASR’) helps to deter common challenges among mall owners and management companies such as trespassers, criminal mischief, and catalytic converter…

Continue Reading

ThursdayMay 05, 2022 1:54 pm

QualityStocksNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Announces Update on Installation of One of Illinois’ Largest Rooftop Solar Power Facilities

Correlate Infrastructure Partners (OTCQB: CIPI) today announced that final engineering, permitting and interconnection work has begun on the Geneva, Illinois, facility where the company has contracted to install a large-scale rooftop solar project. The massive project is being constructed at the headquarters of Continental Envelope and is located at the company’s manufacturing plant, which has the capacity to produce 2 billion envelopes per year. The clean energy system complements Continental’s “Pushing the Envelope” Community Gardens surrounding the property. “Correlate Infrastructure Partners loves supporting ESG-focused businesses that are making a true difference in their industries and communities. This attractive project makes…

Continue Reading

ThursdayMay 05, 2022 1:19 pm

QualityStocksNewsBreaks – SPYR Technologies’ (SPYR) Applied Magix Considers Developing Commercial Software to Support Non-Branded Products

SPYR (OTCQB: SPYR) is a technology company whose subsidiary, Applied Magix Inc., develops and resells Apple(R) ecosystem compatible products in the growing multibillion-dollar smart home and connected car markets. The company today announced that it is considering developing software for non-branded smart products in order to improve the user experience (“UX”), enhancing available products without the burden of new hardware development. “In our research into viable products to manufacture or carry, we have come across a number of manufacturers in China, with well-engineered, often excellent hardware, yet abysmally poor software. Since the software is the main point of interaction for…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered